Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Warfarin in Cerebral Venous Thrombosis
NCT03747081Phase 2Unknown
- Start
- Sep 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of rivaroxaban in Cerebral venous thrombosis (CVT) (2 arms). Primary endpoint: modified Rankin Scale at 3 months. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
Cerebral venous thrombosis (CVT)
Beyond the preview
Go deeper on NCT03747081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03747081.